ES2357853T3 - Uso de clasificadores de actividad génica para la clasificación in vitro de perfiles de expresión génica de pacientes con fallo multiorgánico infeccioso/no infeccioso. - Google Patents

Uso de clasificadores de actividad génica para la clasificación in vitro de perfiles de expresión génica de pacientes con fallo multiorgánico infeccioso/no infeccioso. Download PDF

Info

Publication number
ES2357853T3
ES2357853T3 ES06725094T ES06725094T ES2357853T3 ES 2357853 T3 ES2357853 T3 ES 2357853T3 ES 06725094 T ES06725094 T ES 06725094T ES 06725094 T ES06725094 T ES 06725094T ES 2357853 T3 ES2357853 T3 ES 2357853T3
Authority
ES
Spain
Prior art keywords
seq
infectious
expression
patients
classification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06725094T
Other languages
English (en)
Spanish (es)
Inventor
Stefan Russwurm
Konrad Reinhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIRS Lab GmbH
Original Assignee
SIRS Lab GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIRS Lab GmbH filed Critical SIRS Lab GmbH
Application granted granted Critical
Publication of ES2357853T3 publication Critical patent/ES2357853T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES06725094T 2005-03-21 2006-03-16 Uso de clasificadores de actividad génica para la clasificación in vitro de perfiles de expresión génica de pacientes con fallo multiorgánico infeccioso/no infeccioso. Active ES2357853T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005013013A DE102005013013A1 (de) 2005-03-21 2005-03-21 Verwendung von Genaktivitäts-Klassifikatoren für die in vitro Klassifizierung von Genexpressionsprofilen von Patienten mit infektiösem/nichtinfektiösem Multiorganversagen
DE102005013013 2005-03-21

Publications (1)

Publication Number Publication Date
ES2357853T3 true ES2357853T3 (es) 2011-05-03

Family

ID=36838697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06725094T Active ES2357853T3 (es) 2005-03-21 2006-03-16 Uso de clasificadores de actividad génica para la clasificación in vitro de perfiles de expresión génica de pacientes con fallo multiorgánico infeccioso/no infeccioso.

Country Status (9)

Country Link
US (1) US8236496B2 (fr)
EP (1) EP1863928B1 (fr)
CN (1) CN101146914A (fr)
AT (1) ATE498694T1 (fr)
BR (1) BRPI0609705A2 (fr)
CA (1) CA2602543C (fr)
DE (2) DE102005013013A1 (fr)
ES (1) ES2357853T3 (fr)
WO (1) WO2006100203A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084082A1 (en) 1997-03-07 2006-04-20 Human Genome Sciences, Inc. 186 human secreted proteins
US20080070235A1 (en) * 2003-04-02 2008-03-20 Sirs-Lab Gmbh Method for Recognizing Acute Generalized Inflammatory Conditions (Sirs), Sepsis, Sepsis-Like Conditions and Systemic Infections
DE102004009952B4 (de) * 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis
DE102004015605B4 (de) * 2004-03-30 2012-04-26 Sirs-Lab Gmbh Verfahren zur Vorhersage des individuellen Krankheitsverlaufs bei Sepsis
DE102004049897B4 (de) * 2004-10-13 2007-11-22 Sirs-Lab Gmbh Verfahren zur Unterscheidung zwischen nichtinfektiösen und infektiösen Ursachen eines Multiorganversagens
US7485468B2 (en) 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
US8673268B2 (en) 2004-10-15 2014-03-18 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
DE102006027842B4 (de) 2006-06-16 2014-07-31 Analytik Jena Ag Verfahren zur Feststellung der Infektionsquelle bei Fieber unklarer Genese
DE102008000715B9 (de) * 2008-03-17 2013-01-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen
WO2010087594A2 (fr) * 2009-01-28 2010-08-05 한국생명공학연구원 Utilisation de cd93 ou d'un fragment soluble de celui-ci
EP2309001A1 (fr) 2009-09-23 2011-04-13 SIRS-Lab GmbH Procédé de détermination et de différenciation in vitro d'états physiopathologiques
DE102009044085A1 (de) 2009-09-23 2011-11-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfassung und Unterscheidung von pathophysiologischen Zuständen
US20110076685A1 (en) * 2009-09-23 2011-03-31 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
DE102011005235B4 (de) 2011-03-08 2017-05-24 Sirs-Lab Gmbh Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
EP2520662A1 (fr) * 2011-05-04 2012-11-07 Stichting Sanquin Bloedvoorziening Supports et procédés permettant de déterminer le risque de défaillance multiple d'organes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US5830679A (en) 1996-03-01 1998-11-03 New England Medical Center Hospitals, Inc. Diagnostic blood test to identify infants at risk for sepsis
DE10041215A1 (de) 1999-12-22 2001-10-04 Dade Behring Marburg Gmbh Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
EP1270740A1 (fr) 2001-06-29 2003-01-02 SIRS-Lab GmbH Biopuce et son utilisation pour la détermination de l'inflammation
US7465555B2 (en) 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
CN1742087A (zh) 2002-11-12 2006-03-01 贝克顿迪金森公司 使用生物标记谱诊断脓毒或者sirs
CA2505902A1 (fr) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnostic pour la septicemie ou le sirs au moyen de profils de biomarqueurs
US20080070235A1 (en) 2003-04-02 2008-03-20 Sirs-Lab Gmbh Method for Recognizing Acute Generalized Inflammatory Conditions (Sirs), Sepsis, Sepsis-Like Conditions and Systemic Infections
DE102004009952B4 (de) 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis

Also Published As

Publication number Publication date
BRPI0609705A2 (pt) 2010-04-20
DE102005013013A1 (de) 2006-09-28
DE502006008908D1 (de) 2011-03-31
US8236496B2 (en) 2012-08-07
ATE498694T1 (de) 2011-03-15
WO2006100203A2 (fr) 2006-09-28
EP1863928A2 (fr) 2007-12-12
CN101146914A (zh) 2008-03-19
WO2006100203A3 (fr) 2007-07-05
CA2602543C (fr) 2014-12-30
CA2602543A1 (fr) 2006-09-28
US20090325152A1 (en) 2009-12-31
EP1863928B1 (fr) 2011-02-16

Similar Documents

Publication Publication Date Title
ES2357853T3 (es) Uso de clasificadores de actividad génica para la clasificación in vitro de perfiles de expresión génica de pacientes con fallo multiorgánico infeccioso/no infeccioso.
ES2365978T3 (es) Procedimiento para diferenciar entre causas no infecciosas e infecciosas de un fallo multiorgánico.
ES2538504T3 (es) Marcadores en la orina para la detección del cáncer de vejiga
US8288108B2 (en) Expression profiles for predicting septic conditions
CA2874492C (fr) Genes nano-46 et procedes de prediction de l'evolution du cancer du sein
ES2550614T3 (es) Marcadores de expresión génica para predecir la respuesta a la quimioterapia
GB2470707A (en) Method for in vitro detection and differentiation of pathophysiological states
AU2015213486A1 (en) Biomarker signature method, and apparatus and kits therefor
JP2010527577A (ja) 検出方法
AU2005250219A1 (en) Oligonucleotides for cancer diagnosis
US20100086909A1 (en) Method for the prediction of individual disease course in sepsis
TW201120449A (en) Diagnostic methods for determining prognosis of non-small-cell lung cancer
ES2340459B1 (es) Metodo para diagnosticar o determinar la predisposicion genetica a desarrollar miocardiopatia hipertrofica.
CN111647670A (zh) 一种与肾病综合征相关的肠道菌属Faecalitalea及其应用
BR112020012280A2 (pt) composições e métodos para diagnosticar cânceres de pulmão usando perfis de expressão de gene
KR102363515B1 (ko) 약물 반응성 예측용 조성물 및 이의 용도
ES2297900T3 (es) Diagnosis y terapia para la enfermedad obstructiva cronica de las vias respiratorias.
JP2021129513A (ja) びまん性肺胞障害型薬剤性間質性肺炎のｍｉＲＮＡ診断バイオマーカー
WO2014076342A1 (fr) Méthode d'obtention de données utiles pour le diagnostic, le pronostic et la prédiction d'une réponse au traitement de l'adénocarcinome du pancréas
KR102363514B1 (ko) 약물 반응성 예측용 조성물 및 이의 용도
CN108424960A (zh) 一种LncRNA作为深静脉血栓形成诊断标志物的应用
CN108753949A (zh) 血清中circ_0082660作为URSA诊断及妊娠结局评估标志物的应用